Stüve, Olaf

Defining the clinical course of multiple sclerosis: The 2013 revisions

Lublin, F. D., Reingold, S. C., Cohen, J. A., Cutter, G. R., Sørensen, P. S., Thompson, A. J., Wolinsky, J. S., Balcer, L. J., Banwell, B., Barkhof, F., et al. (2014) · Neurology

Multiple Sclerosis Research StudiesPsoriasis: Treatment and Pathogenesis

Cited by 3,177

Type II monocytes modulate T cell–mediated central nervous system autoimmune disease

Weber, M. S., Prod'homme, T., Youssef, S., Dunn, S. E., Rundle, C. D., Lee, L., Patarroyo, J. C., Stüve, O., Sobel, R. A., Steinman, L., et al. (2007) · Nature Medicine

Multiple Sclerosis Research StudiesT-cell and B-cell Immunology

Cited by 447

The utility of cerebrospinal fluid analysis in patients with multiple sclerosis

Stangel, M., Fredrikson, S., Meinl, E., Petzold, A., Stüve, O., & Tumani, H. (2013) · Nature Reviews Neurology

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 229

Pharmacological Properties, Toxicology and Scientific Rationale for the use of Natalizumab (Tysabri®) in Inflammatory Diseases

Stüve, O., & Bennett, J. L. (2007) · CNS Drug Reviews

Multiple Sclerosis Research StudiesCell Adhesion Molecules Research

Cited by 123

Ectopic Lymphoid Follicles in Multiple Sclerosis: Centers for Disease Control?

Negron, A., Stüve, O., & Forsthuber, T. G. (2020) · Frontiers in Neurology

Multiple Sclerosis Research StudiesT-cell and B-cell Immunology

Cited by 47

Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practice

Costello, F., Stüve, O., Weber, M. S., Zamvil, S. S., & Frohman, E. (2007) · Current Opinion in Neurology

Multiple Sclerosis Research StudiesPsoriasis: Treatment and Pathogenesis

Cited by 46